Richter Syndrome - 14 Studies Found

Completed : Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
: Leukemia
: 2007-03-23
:
  • Drug: Cytarabine 1 g/m^2 given
Recruiting : Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation
: Chronic Lymphocytic Leukemia
: 2015-08-24
:
  • Drug: Pembrolizumab IV immunot
Completed : Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL
:
  • B-cell Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Drug: PCI-32765 420 mg PO dail
Active, not recruiting : ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
:
  • Non-hodgkin Lymphoma
  • Multiple Myeloma
  • Hodgkin Lymphoma : 2015-02-07
    :
    • Drug: Acalabrutinib oral
<<< Previous